Pharmaceutical

Genmab’s Tivdak approved in Japan for advanced cervical cancer

Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.

Mar 29, 2025 - 06:00
Genmab’s Tivdak approved in Japan for advanced cervical cancer
Genmab has received approval from Japan's Ministry of Health, Labour and Welfare for its Tivdak to treat cervical cancer.
Read the original article

Tags:

Previous Article

Weill Cancer Hub East launches to transform treatment

Next Article

Soleno wins FDA approval for Prader-Willi hyperphagia treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Could private equity be the future of private practice? A new lobbying group thinks so

STAT+: Could private equity be the future of private pr...

Jan 16, 2024

Biden’s administration initiative aims to advance women’s health conditions

Biden’s administration initiative aims to advance women...

Mar 20, 2024

Opinion: Will there be any emergency doctors to see you in the future?

Opinion: Will there be any emergency doctors to see you...

Mar 20, 2023